Schmidt P J Investment Management Inc. boosted its position in shares of The Allstate Corporation (NYSE:ALL – Free Report) by 2.2% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,447 shares of the insurance provider’s stock after buying an additional 75 shares during the quarter. Schmidt P J Investment Management Inc.’s holdings in Allstate were worth $694,000 at the end of the most recent quarter.
Several other large investors have also bought and sold shares of the company. Solstein Capital LLC boosted its stake in Allstate by 28.8% during the second quarter. Solstein Capital LLC now owns 394 shares of the insurance provider’s stock valued at $79,000 after buying an additional 88 shares in the last quarter. Envestnet Asset Management Inc. boosted its position in shares of Allstate by 3.8% in the 2nd quarter. Envestnet Asset Management Inc. now owns 257,473 shares of the insurance provider’s stock valued at $51,832,000 after purchasing an additional 9,544 shares during the period. Chilton Capital Management LLC purchased a new stake in Allstate in the 2nd quarter worth about $38,000. Resonant Capital Advisors LLC lifted its stake in Allstate by 10.6% in the 2nd quarter. Resonant Capital Advisors LLC now owns 2,146 shares of the insurance provider’s stock worth $434,000 after acquiring an additional 205 shares in the last quarter. Finally, New Hampshire Trust lifted its stake in Allstate by 4.7% in the 2nd quarter. New Hampshire Trust now owns 3,112 shares of the insurance provider’s stock worth $626,000 after acquiring an additional 140 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.
Allstate Stock Down 0.6%
ALL stock opened at $193.37 on Monday. The company has a quick ratio of 0.43, a current ratio of 0.43 and a debt-to-equity ratio of 0.37. The company has a market cap of $50.95 billion, a price-to-earnings ratio of 9.09, a P/E/G ratio of 0.70 and a beta of 0.38. The Allstate Corporation has a twelve month low of $176.00 and a twelve month high of $215.70. The business has a 50 day moving average price of $204.27 and a two-hundred day moving average price of $201.14.
Analysts Set New Price Targets
A number of brokerages recently weighed in on ALL. Citigroup raised Allstate to a “hold” rating in a research note on Wednesday, August 13th. Wall Street Zen upgraded Allstate from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Evercore ISI set a $233.00 price target on Allstate and gave the company an “in-line” rating in a research note on Wednesday, October 1st. Wells Fargo & Company cut their price target on Allstate from $200.00 to $197.00 and set an “equal weight” rating for the company in a report on Friday. Finally, Wolfe Research upgraded Allstate to a “strong-buy” rating in a report on Tuesday, September 16th. Two research analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $234.27.
Get Our Latest Stock Analysis on Allstate
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- Trading Halts Explained
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- When to Sell a Stock for Profit or Loss
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Is Landstar the Next Big Winner in Transportation Stocks?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.
